Skip to content

Effect of vWF level and ADAMTS-13 content on thrombosis and different turnover in cirrhosis portal vein system

Effect of vWF level and ADAMTS-13 content on thrombosis and different turnover in cirrhosis portal vein system

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025035
Enrollment
Unknown
Registered
2019-08-08
Start date
2018-07-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cirrhosis of liver

Interventions

Case series:No

Sponsors

Beijing Youan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Man and woman aged 18 to 70 years with cirrhosis portal hypertension combined with thrombus caused by any reason; 2) The patient's clinical performance and imaging examination meet the diagnostic criteria for cirrhosis; 3) abdominal CT or nuclear magnetic diagnosis combined with PVT; 4) Signature of PIC.

Exclusion criteria

Exclusion criteria: 1) With abdominal pain and other intestinal ischemic manifestations; 2) Past history of splenectomy; 3) Participating in other clinical trials or applying anticoagulant drugs in the last 3 months; 4) After liver transplantation; 5) Combine other systems of serious diseases to affect the clinical return of patients, such as serious heart, lungs, kidney diseases, blood system, malignant tumors, etc.; 6) Pregnancy and other conditions that researchers believe are not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
vWF level;ADAMTS-13 content;Gene testing;New blood clotting 4;

Countries

China

Contacts

Public ContactWei Lin

Beijing Youan Hospital, Capital Medical University

linwei1978@sina.com+86 13301379180

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026